Nursing home performance in resident care in the United States: is it only a matter of for-profit versus not-for-profit? [0.03%]
美国的养老院绩效与病人护理有多大关系：仅仅关乎是否盈利吗？
Frederic H Decker
Frederic H Decker
Poorer resident care in US for-profit relative to not-for-profit nursing homes is usually blamed on the profit motive. But US nursing home performance may relate to Medicaid public financing in a manner qualifying the relationship between o...
Naoki Ikegami,John Creighton Campbell
Naoki Ikegami
Tony Barnett
Tony Barnett
Daniel Callahan
Daniel Callahan
Consumer-directed health care (CDHC) is one of the basic ideas that has emerged in recent years as a way of bringing greater efficiency and cost control into health care. Its principal aims are to give patients greater control over their ca...
Valuing lives and life years: anomalies, implications, and an alternative [0.03%]
重视生命与寿命年的价值：反常现象、影响及替代方案
Paul Dolan,Robert Metcalfe,Vicki Munro et al.
Paul Dolan et al.
Many government interventions seek to reduce the risk of death. The value of preventing a fatality (VPF) is the monetary amount associated with each statistical death that an intervention can be expected to prevent. The VPF has been estimat...
Willingness to pay for alternative policies for patients with Alzheimer's Disease [0.03%]
阿尔茨海默病患者替代性政策的支付意愿
Miguel A Negrín,Jaime Pinilla,Carmelo J León
Miguel A Negrín
This paper focuses on eliciting the willingness to pay (WTP) for policy measures aimed at improving the health care offered to patients suffering from Alzheimer's disease (AD). We utilize a discrete choice experiment (DCE) approach for the ...
Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards [0.03%]
应对法律和政治障碍以实现全球医药可及性：纠正《与贸易有关的知识产权协定》和超TRIPS标准带来的影响的方法探讨
Jillian Clare Cohen-Kohler,Lisa Forman,Nathaniel Lipkus
Jillian Clare Cohen-Kohler
Despite myriad programs aimed at increasing access to essential medicines in the developing world, the global drug gap persists. This paper focuses on the major legal and political constraints preventing implementation of coordinated global...
David McDaid
David McDaid